about
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnosti...
Read More
14.77
-0.57
(-3.72%)
8.7M
XNAS Volume
XNAS 18 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Erasca Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..